SAGE sagerx.com: Sof marja

sagerx.com (SAGE) - korporativ logo

Sage Therapeutics, Inc. (SAGE) Biogen bilan strategik ittifoqdan foydalangan holda, nevrologik patologiyalar va depressiyalarni davolashga ixtisoslashgan. Shartnomaviy ishlab chiqaruvchilar orqali diversifikatsiya qilingan ta'minot zanjirlari biznes barqarorligini ta'minlaydi. GURU.Markets ma'lumotlarida taqdim etilgan kompaniyaning tijorat foyda marjasi joriy qiymat sifatida -427.80 darajasini ko'rsatmoqda, bu esa markaziy nerv tizimi (CNS) buzilishlarini davolash bo'yicha R&D loyihalari pipeline-ini tahlil qilishda hisobga olinishi kerak bo'lgan muhim omildir.

sagerx.com (SAGE) - Sof marja 04.07.2022dan 16.08.2025gacha

Sage Therapeutics, Inc - tahliliy kesimlar va asosiy koʻrsatkichlar (SAGE)

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Sage Therapeutics Inc. - SAGE
Sage Therapeutics Inc. tayyor mahsulotlari

Investorlar biznes modelining barqarorligini kompaniyaning daromad birligi uchun sof foyda keltirish qobiliyati orqali baholaydilar. Sage Therapeutics, Inc. (SAGE) uchun GABA modulyatorlariga berilgan eksklyuziv FDA tasdiqlari tufayli generik dori vositalariga bog'liqlik minimal darajada. Sof foyda marjasini tahlil qilish barcha xarajatlardan keyin qolgan foyda ulushini ochib beradi. Ushbu ko'rsatkich xarajatlarni boshqarish samaradorligini va fundamental daromadlilikni o'lchaydi. Barqaror tendentsiya korxonaning raqobatbardoshlik ustunligini tasdiqlaydi.

Asosiy raqobatchilar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ADXN (Addex Therapeutics Ltd) - Sof foyda normasi|Sof marja alzamend.com ALZN|Kompaniya sotuv marjasi Cyclerion Therapeutics (CYCN)|Protagenic - Sotuvning sof marjinal rentabelligi|Sof foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Sotuvning sof marjinal rentabelligi|Avenue Therapeutics Inc. (ATXI) - Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Cara Therapeutics Inc|Sof marja Chromocell Therapeutics (CHRO)|Kompaniyaning sof rentabelligi ELYM|Sof marja Intra-Cellular ITCI|LBPH: Sotuvning sof rentabelligi|MRNS - Sof marja|NKGen Biotech, Inc. (NKGN) - Sof foyda bo'yicha sotuv rentabelligi|neurobopharma.com (NRBO) - Sof marja|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel